argenx SE (FRA:1AE)
€ 808.4 +51 (+6.73%) Market Cap: 49.86 Bil Enterprise Value: 45.36 Bil PE Ratio: 41.27 PB Ratio: 7.89 GF Score: 78/100

Q1 2026 argenx SE Earnings Call Transcript

May 07, 2026 / 12:30PM GMT
Release Date Price: €713 (+4.45%)
Operator

(Operator instructions) After the speaker and it's been placed on mute to prevent any background noise.

After the speaker's remarks, Uthere will be a question-and-answer session. Thank you. I'd like to introduce Beth DelGiacco, Vice President of Corporate Affairs. You may now begin your call.

Beth DelGiacco
argenx SE - Vice President, Corporate Communications & Investor Relations

Thank you. A press release was issued earlier today with our first-quarter 2026 financial results and business update. This can be found on our website along with the presentation for today's webcast.

Before we begin on slide 2, I'd like to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory timelines, the potential success of our product candidates, financial projections, and upcoming milestones. Actual results may differ materially from those indicated by these statements.

Argenix is not under any obligation to update statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot